Condition Location Conditions Locations Treatment Type Trial Phase Trial Status Paid Participation Trial Details Key Eligibility Criteria 1400 Participants Needed Trial Details Key Eligibility Criteria 454 Participants Needed Trial Details Key Eligibility Criteria 506 Participants Needed Trial Details Key Eligibility Criteria 312 Participants Needed Trial Details Key Eligibility Criteria 132 Participants Needed Trial Details Key Eligibility Criteria 2749 Participants Needed Trial Details Key Eligibility Criteria 15374 Participants Needed Trial Details Key Eligibility Criteria 2996 Participants Needed Trial Details Key Eligibility Criteria 400 Participants Needed Trial Details Key Eligibility Criteria 146 Participants Needed Trial Details Key Eligibility Criteria 11000 Participants Needed Trial Details Key Eligibility Criteria 11800 Participants Needed Trial Details Key Eligibility Criteria 3853 Participants Needed Trial Details Key Eligibility Criteria 3082 Participants Needed Trial Details Key Eligibility Criteria 300 Participants Needed Trial Details Key Eligibility Criteria 5531 Participants Needed Trial Details Key Eligibility Criteria 14012 Participants Needed Trial Details Key Eligibility Criteria 2542 Participants Needed Trial Details Key Eligibility Criteria 350 Participants Needed Trial Details Key Eligibility Criteria 466 Participants Needed "As a healthy volunteer, I like to participate in as many trials as I'm able to

Less Common Side Effects: In rare cases, Rybelsus can lead to more serious conditions such as: Allergic responses (such as hives, swelling, or breathing difficulties) Pancreatitis (inflammation of the pancreas) Gallbladder disease Kidney problems Liver problems Heightened risk of hypoglycemia (low blood sugar) in individuals using insulin or other diabetes medications Hair loss Skin rash Rybelsus may cause hypoglycemia, or low blood sugar, particularly when its used in combination with other diabetes medications like insulin
Because of this limited tool-kit of recombinant production, it is often paired with downstream chemical (or enzymatic) steps to add non-natural modifications While we did capture whether peptides are cyclical or linear, we did not look at more granular features (e.g., non-canonical amino acids, site-specific modifications)
GLP-1 medications reduce appetite enough that many people naturally drift toward eating very little, and when total food intake drops, protein is often the first casualty
Common side effects include nausea, vomiting, diarrhea, constipation, and injection site reactions